Hepatitis, Toxic
|
0.200 |
Therapeutic
|
disease |
CTD_mouse |
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
|
23628428 |
2013 |
Drug-Induced Liver Disease
|
0.200 |
Therapeutic
|
phenotype |
CTD_mouse |
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
|
23628428 |
2013 |
Hepatitis, Drug-Induced
|
0.200 |
Therapeutic
|
disease |
CTD_mouse |
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
|
23628428 |
2013 |
Drug-Induced Acute Liver Injury
|
0.200 |
Therapeutic
|
disease |
CTD_mouse |
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
|
23628428 |
2013 |
Chemical and Drug Induced Liver Injury
|
0.200 |
Therapeutic
|
disease |
CTD_mouse |
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
|
23628428 |
2013 |
Chemically-Induced Liver Toxicity
|
0.200 |
Therapeutic
|
disease |
CTD_mouse |
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.
|
23628428 |
2013 |
Hepatoma, Morris
|
0.200 |
Biomarker
|
disease |
CTD_mouse |
Expression profiling and identification of novel genes in hepatocellular carcinomas.
|
11420682 |
2001 |
Hepatoma, Novikoff
|
0.200 |
Biomarker
|
disease |
CTD_mouse |
Expression profiling and identification of novel genes in hepatocellular carcinomas.
|
11420682 |
2001 |
Liver Neoplasms, Experimental
|
0.200 |
Biomarker
|
phenotype |
CTD_mouse |
Expression profiling and identification of novel genes in hepatocellular carcinomas.
|
11420682 |
2001 |
Experimental Hepatoma
|
0.200 |
Biomarker
|
disease |
CTD_mouse |
Expression profiling and identification of novel genes in hepatocellular carcinomas.
|
11420682 |
2001 |
Smoking
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
|
27488534 |
2016 |
Smoking Behaviors
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
|
27488534 |
2016 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In summary, our results confirmed for the first time that a four-CYP gene (CYP1A2, CYP2E1, CYP2A7, and PTGIS) signature is associated with fast-growing HCC, and CYP2C8 is associated with patient survival.
|
30971588 |
2020 |
Chronic Obstructive Airway Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Previously reported associations on chromosome 19 showed suggestive and directionally consistent associations among common variants (RAB4, CYP2A7, and CYP2B6) and for rare variants (CYP2A7) among COPDGene NHW subjects.
|
29767774 |
2019 |
Carcinogenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
These data signify that CYP2A and CYP1A isoforms expressed in the target urothelium bioactivate 4-ABP and AαC, respectively, and may be a critical feature of aromatic amine-induced urinary bladder carcinogenesis.
|
31203411 |
2019 |
Heartburn
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The fruit quality (total soluble solids content and titratable acidity) was not negatively affected by CPA-7.
|
30166146 |
2018 |
Malignant neoplasm of breast
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These include four loci that were associated (unadjusted P<0.05) with breast cancer (GTF2H2, ZNF385B, NAALADL2 and PSG5), and two loci associated with ovarian cancer (CYP2A7 and OR2A1).
|
28145423 |
2017 |
Drug habituation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
However, the combination of gastrointestinal digestion and habituation on the fruit resulted in a significant reduction of CPA-7 populations (by 2 log<sub>10</sub> more after 7d of incubation than on inoculation day) as well as in the decrease of its adhesiveness (by 0.8 log<sub>10</sub>) and invasiveness (to undetectable levels).
|
28964998 |
2017 |
Adenomatous Polyposis Coli
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
|
28306719 |
2017 |
Atrial Premature Complexes
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
|
28306719 |
2017 |
Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These include four loci that were associated (unadjusted P<0.05) with breast cancer (GTF2H2, ZNF385B, NAALADL2 and PSG5), and two loci associated with ovarian cancer (CYP2A7 and OR2A1).
|
28145423 |
2017 |
ovarian neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These include four loci that were associated (unadjusted P<0.05) with breast cancer (GTF2H2, ZNF385B, NAALADL2 and PSG5), and two loci associated with ovarian cancer (CYP2A7 and OR2A1).
|
28145423 |
2017 |
Malignant neoplasm of ovary
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These include four loci that were associated (unadjusted P<0.05) with breast cancer (GTF2H2, ZNF385B, NAALADL2 and PSG5), and two loci associated with ovarian cancer (CYP2A7 and OR2A1).
|
28145423 |
2017 |
Familial (FPAH)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
|
28306719 |
2017 |
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
|
28306719 |
2017 |